154207
Pandemic Influenza Triage in the Clinical Setting
Tuesday, November 6, 2007: 3:30 PM
Kimberley Shoaf, DrPH
,
Center for Public Health and Disasters, UCLA, Los Angeles, CA
Jennifer Schlesinger, MPH
,
Center for Public Health and Disasters, UCLA, Los Angeles, CA
Eva Klein Selski
,
Center for Public Health and Disasters, UCLA, Los Angeles, CA
Little is known about the ability of the clinical community to deal quickly and effectively with a potentially overwhelming surge of pandemic influenza patients. Key informant interviews were conducted using an IRB approved protocol to assess attitudes and expectations of emergency physicians, emergency nurses, intensive care clinicians, hospital nursing supervisors, hospital administrators and infection control personnel. Using the 76 emergency receiving hospitals in Los Angeles County, we randomly selected a hospital for each of these six health care worker categories. Each informant participated in a structured interview concerning supplies/resources, triage, quality of care and decision-making. At the conclusion of the interview, each informant was asked to provide the contact information for at least two others within their respective professional group. Interviews were transcribed and coded for key themes using qualitative analytical software. Results of these interviews will be presented with a discussion of the implications for health care providers to adhere to modified policies and standards of practice in a pandemic setting.
Learning Objectives: 1. List three triage classifications for pandemic influenza patients presenting to emergency departments.
2. Discuss differences in expected adherence to clinical care modifications across different health care providers.
3. Articulate concerns about the consequences of adequacy of resources and supplies in an influenza pandemic.
Keywords: Health Care Workers, Ethics
Presenting author's disclosure statement:Any relevant financial relationships? No Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|